The Research and Development Team at Purespring Therapeutics is dedicated to advancing AAV gene therapy solutions for kidney diseases. This multidisciplinary team collaborates to design and optimize therapeutic candidates, develop robust bioprocessing and analytical methods, and ensure the quality and efficacy of the therapies through rigorous testing and validation. Their innovative efforts aim to translate scientific discoveries into effective treatments for patients globally.
Ambra Cappelletto
Principal Scientist
Carolina Pinto Ricar...
Principal Analytical Developme...
James Matthews
Scientist
João Marques
Principal Downstream Scientist
Kritima Gurung
Senior Scientist
Kushal Paudel
Senior Scientist
Mark Bell
Principal Bioprocessing Scient...
Martin Madill
Senior Scientist
Mathulah Sriskandara...
R & D Scientist
Umar Ishaque
Associate Scientist
View all